13/11/2024  11:16:16 Chg. +0.80 Volume Bid11:16:20 Demandez à11:16:20 Capitalisation boursière Dividende Y. Rapport P/E
217.40CHF +0.37% 9,039
Chiffrre d'affaires: 1.96 Mio.
217.20Bid taille: 38 217.80Ask la taille: 40 2.76 Mrd.CHF 0.69% 20.91

Description de l'entreprise

Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
 

Conseil d'administration & Conseil de surveillance

PDG
Dr. Achim von Leoprechting
Conseil d'administration
Tania Micki, Andreas Wilhelm, Dr. Wael Yared, Erik Norström, Ingrid Pürgstaller, Ralf Griebel, Ulrich Kanter, Mukta Acharya
Conseil de surveillance
Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Myra Eskes, Matthias Gillner, Monica Manotas
 

Données de l'entreprise

Nom: Tecan Group AG
Adresse: Seestrasse 103,CH-8708 Männedorf
Téléphone: +41-44-922-8111
Fax: +41-44-922-8112
Courriel: info@tecan.com
Internet: www.tecan.com
Industrie: Healthcare
Secteur: Medical Products
Sous-secteur: Advanced Medical Devices
Fin de l'exercice financier: 31/12
Flotte libre: 61.50%
IPO date: -

Relations avec les investisseurs

Nom: Martin Brändle
Téléphone IR: +41-44-922-8430
IR-Fax: +41-44-922-8889
E-mail IR: investor@tecan.com

Principaux actionnaires

Autres
 
55.70%
Chase Nominees Ltd.
 
12.20%
UBS Fund Management AG
 
5.10%
APG Algemene Pensioen Groep N.V
 
4.50%
BlackRock Inc.
 
4.50%
FIL Limited, Pembroke
 
3.00%
Candriam Luxembourg
 
3.00%
Swisscanto Fondsleitung AG
 
3.00%
Credit Suisse Funds AG
 
3.00%
Autres
 
6.00%